Is It Too Late to Buy Viking Therapeutics Stock? - MSN

Viking Therapeutics intends to keep its innovative wheel rolling. And based on the company's track record so far and the several candidates it has in clinical trials, especially VK2735, things ...

CouponFollow Extension

54%
OFF

Is It Too Late To Buy Viking Therapeutics Stock?

1 week from now

Apr 6, 2024 · In late February, clinical-stage biopharma Viking Therapeutics (VKTX-0.54%) made waves when it released impressive phase 2 trial data for its obesity drug candidate, VK2735. …

fool.com

285%
OFF

Up 285% YTD, Is It Too Late To Buy This Biotech Stock? - MSN

1 week from now

Viking Therapeutics has achieved impressive progress this year with its pipeline candidates, and the anticipated FDA approval of its GLP-1 treatments could further enhance its market position.

msn.com

$1000
OFF

Is Viking Therapeutics A Buy On The Dip? - MSN

1 week from now

If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves: Amazon: if you invested $1,000 when we ...

msn.com

528%
OFF

Is Viking Therapeutics Stock A Buy? - MSN

1 week from now

W ith Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, it's easy to wonder if the opportunity to buy its stock is too good to be true -- and a bit …

msn.com

FAQs about Is It Too Late to Buy Viking Therapeutics Stock? - MSN Coupon?

Is it too late to buy Viking Therapeutics stock?

In conclusion, no, it is not too late to buy Viking Therapeutics stock. Just be aware that the road to commercializing its first medicine is probably slightly riskier than some may believe, and be ready to hold onto your shares for a few years while its clinical trials play out. Alex Carchidi has no position in any of the stocks mentioned. ...

Did investors miss a chance to get in on Viking Therapeutics?

In the wake of that news, shares surged, and they are now up more than 300% year to date. With that big share price move in the rear-view mirror, have investors missed their chance to get in on the next big player in weight loss? Viking Therapeutics stock is on a roll, but... ...

Should you buy Viking Therapeutics?

But even in the midst of this momentum, investors should be aware of some risk factors before scooping up shares of Viking. Viking Therapeutics is still a clinical-stage company -- none of its products has been approved by regulators for commercialization and sale. ...

Should you buy Viking Therapeutics (vktx)?

Up 260% so far this year, shares of Viking Therapeutics ( VKTX -1.90%) are a hot commodity thanks to its increasingly promising therapies in development to treat obesity. But as wise investors know, buying a small biotech stock immediately after it has significantly gained in value can be a especially risky proposition. ...

Is Viking a good long-term buy?

There's so much future growth priced in that it may not take much for the stock to fall from these heights. While Viking could still prove to be a good long-term buy, it is also a high-risk investment. For most investors, it may be best to take a wait-and-see approach with the stock. David Jagielski has no position in any of the stocks mentioned. ...

Should you buy Viking biotech?

Viking isn't a biotech that will need to take out a lot of debt or issue a lot of new shares to get its therapies out the door. Therefore, buying its stock won't leave you at as high of a risk of your shares getting diluted by new issuance like buying many other biotech stocks would. ...